BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 34414566)

  • 1. Impact of comorbidities on the disability progression in multiple sclerosis.
    Maric G; Pekmezovic T; Tamas O; Veselinovic N; Jovanovic A; Lalic K; Mesaros S; Drulovic J
    Acta Neurol Scand; 2022 Jan; 145(1):24-29. PubMed ID: 34414566
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence of comorbidities in Multiple Sclerosis and impact on physical disability according to disease phenotypes.
    Ciampi E; Uribe-San-Martin R; Soler B; Molnar K; Reyes D; Keller K; Carcamo C
    Mult Scler Relat Disord; 2020 Nov; 46():102565. PubMed ID: 33039942
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Psychiatric comorbidity is associated with disability progression in multiple sclerosis.
    McKay KA; Tremlett H; Fisk JD; Zhang T; Patten SB; Kastrukoff L; Campbell T; Marrie RA;
    Neurology; 2018 Apr; 90(15):e1316-e1323. PubMed ID: 29523642
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of physical comorbidities on disability progression in multiple sclerosis.
    Zhang T; Tremlett H; Zhu F; Kingwell E; Fisk JD; Bhan V; Campbell T; Stadnyk K; Carruthers R; Wolfson C; Warren S; Marrie RA;
    Neurology; 2018 Jan; 90(5):e419-e427. PubMed ID: 29298855
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vascular comorbidity is associated with more rapid disability progression in multiple sclerosis.
    Marrie RA; Rudick R; Horwitz R; Cutter G; Tyry T; Campagnolo D; Vollmer T
    Neurology; 2010 Mar; 74(13):1041-7. PubMed ID: 20350978
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prediction of long-term disability in Chinese patients with multiple sclerosis: A prospective cohort study.
    Zhang Y; Xu Y; Xu T; Yin H; Zhu Y; Peng B; Cui L
    Mult Scler Relat Disord; 2020 Nov; 46():102461. PubMed ID: 32862039
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes in the Risk of Reaching Multiple Sclerosis Disability Milestones In Recent Decades: A Nationwide Population-Based Cohort Study in Sweden.
    Beiki O; Frumento P; Bottai M; Manouchehrinia A; Hillert J
    JAMA Neurol; 2019 Jun; 76(6):665-671. PubMed ID: 30882868
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Concomitant autoimmunity and risk of multiple sclerosis disability worsening.
    Binzer S; Hillert J; Manouchehrinia A
    Mult Scler Relat Disord; 2024 May; 87():105637. PubMed ID: 38761694
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Disability measurement in Multiple Sclerosis patients 55 years and older: What is the Expanded Disability Status Scale really telling clinicians?
    Lynch S; Baker S; Nashatizadeh M; Thuringer A; Thelen J; Bruce J
    Mult Scler Relat Disord; 2021 Apr; 49():102724. PubMed ID: 33609959
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The prevalence of comorbidities in patients with multiple sclerosis: population-based registry data.
    Maric GD; Pekmezovic TD; Mesaros ST; Tamas OS; Ivanovic JB; Martinovic VN; Andabaka MM; Jovanovic AL; Veselinovic ND; Kisic-Tepavcevic DB; Drulovic JS
    Neurol Sci; 2021 May; 42(5):1887-1893. PubMed ID: 32964347
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long term effect of delayed treatment on disability in patients with paediatric onset multiple sclerosis: A prospective Danish cohort study.
    Kopp TI; Blinkenberg M; Petersen T; Sorensen PS; Magyari M
    Mult Scler Relat Disord; 2020 May; 40():101956. PubMed ID: 32007654
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is benign MS really benign? What a meaningful classification beyond the EDSS must take into consideration.
    Ellenberger D; Flachenecker P; Haas J; Hellwig K; Paul F; Stahmann A; Warnke C; Zettl UK; Rommer PS;
    Mult Scler Relat Disord; 2020 Nov; 46():102485. PubMed ID: 32980646
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Substantial adverse association of visual and vascular comorbidities on visual disability in multiple sclerosis.
    Marrie RA; Cutter G; Tyry T
    Mult Scler; 2011 Dec; 17(12):1464-71. PubMed ID: 21844067
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alcohol, coffee, fish, smoking and disease progression in multiple sclerosis.
    D'hooghe MB; Haentjens P; Nagels G; De Keyser J
    Eur J Neurol; 2012 Apr; 19(4):616-24. PubMed ID: 22117611
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association between sun exposure habits and disease progression in multiple sclerosis.
    Wu J; Olsson T; Alfredsson L; Hedström AK
    Eur J Neurol; 2024 Jun; 31(6):e16269. PubMed ID: 38440929
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The impact of the comorbid seizure/epilepsy on the health related quality of life in people with multiple sclerosis: an international multicentric study.
    Drulovic J; Pekmezovic T; Tamas O; Adamec I; Aleksic D; Andabaka M; Basic Kes V; Butkovic Soldo S; Cukic M; Despinic L; Dincic E; Djelilovic Vranic J; Grgic S; Habek M; Hristova SI; Ivanovic J; Jovanovic A; Jovicevic V; Krbot Skoric M; Kuzmanovski I; Maric G; Mesaros S; Milanov IG; Miletic Drakulic S; Sinanovic O; Skarpa Prpic I; Sremec J; Tadic D; Toncev G; Sokic D
    Front Immunol; 2023; 14():1284031. PubMed ID: 38022568
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association between use of interferon beta and progression of disability in patients with relapsing-remitting multiple sclerosis.
    Shirani A; Zhao Y; Karim ME; Evans C; Kingwell E; van der Kop ML; Oger J; Gustafson P; Petkau J; Tremlett H
    JAMA; 2012 Jul; 308(3):247-56. PubMed ID: 22797642
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of the Expanded Disability Status Scale and the Multiple Sclerosis Functional Composite as clinical endpoints in multiple sclerosis clinical trials: quantitative meta-analyses.
    Bin Sawad A; Seoane-Vazquez E; Rodriguez-Monguio R; Turkistani F
    Curr Med Res Opin; 2016 Dec; 32(12):1969-1974. PubMed ID: 27603119
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Smoking does not influence disability accumulation in primary progressive multiple sclerosis.
    Javizian O; Metz LM; Deighton S; Koch MW
    Eur J Neurol; 2017 Apr; 24(4):624-630. PubMed ID: 28239937
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Progression, symptoms and psychosocial concerns among those severely affected by multiple sclerosis: a mixed-methods cross-sectional study of Black Caribbean and White British people.
    Koffman J; Gao W; Goddard C; Burman R; Jackson D; Shaw P; Barnes F; Silber E; Higginson IJ
    PLoS One; 2013; 8(10):e75431. PubMed ID: 24098384
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.